EyePoint Pharmaceuticals, Inc. Contracts & Agreements

122 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Nonstatutory Stock Option Granted Under pSivida Corp. 2008 Incentive Plan
Bonus & Incentive Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
2008
First Amendment to Northbridge Lease, dated September 30, 2024, by and between EyePoint Pharmaceuticals US, Inc. and 600 CPK LLC
Lease Agreements
EyePoint Pharmaceuticals, Inc.
2024
Memorandum of Understanding, dated August 26, 2024, by and between EyePoint Pharmaceuticals, Inc. and Ocumension Therapeutics
MOUs
EyePoint Pharmaceuticals, Inc.
2024
Underwriting Agreement, dated October 29, 2024, by and between EyePoint Pharmaceuticals, Inc. and J.P. Morgan Securities LLC
Underwriting Agreements
EyePoint Pharmaceuticals, Inc.
2024
Severance Agreement and General Release, dated August 6, 2024, by and between EyePoint Pharmaceuticals, Inc. and Nancy S. Lurker
Severance Agreements
EyePoint Pharmaceuticals, Inc.
2024
EyePoint Pharmaceuticals, Inc. Amendment No 1. to 2023 Long-Term Incentive Plan
Bonus & Incentive Agreements
EyePoint Pharmaceuticals, Inc.
2024
EyePoint Pharmaceuticals, Inc. Amendment No 2. to 2019 Employee Stock Purchase Plan
Stock Agreements
EyePoint Pharmaceuticals, Inc.
2024
Employment Agreement, dated March 4, 2024, by and between EyePoint Pharmaceuticals, Inc. and Ramiro Ribeiro, M.D., Ph.D
Employment Agreements
EyePoint Pharmaceuticals, Inc.
2024
Description of Securities of EyePoint Pharmaceuticals, Inc
EyePoint Pharmaceuticals, Inc.
2024
Form of Indemnification Agreement between EyePoint Pharmaceuticals, Inc. and its officers and directors
Indemnification Agreements
EyePoint Pharmaceuticals, Inc.
2024
Form of Stock Option Award for Inducement Grants to executive officer pursuant to the 2023 LTIP
Stock Agreements
EyePoint Pharmaceuticals, Inc.
2024
Consulting Agreement dated December 18, 2023 by and between Eyepoint Pharmaceuticals, Inc. and John Landis, PhD
Consulting Agreements
EyePoint Pharmaceuticals, Inc.
2024
Underwriting Agreement, dated December 4, 2023, by and between EyePoint Pharmaceuticals, Inc. and J.P. Morgan Securities LLC
Underwriting Agreements
EyePoint Pharmaceuticals, Inc.
2023
Second Amendment to Employment Agreement, dated July 10, 2023, by and between EyePoint Pharmaceuticals, Inc. and Nancy S. Lurker
Employment Agreements
EyePoint Pharmaceuticals, Inc.
2023
Second Amendment to Employment Agreement, dated July 10, 2023, by and between EyePoint Pharmaceuticals, Inc. and Jay S. Duker
Employment Agreements
EyePoint Pharmaceuticals, Inc.
2023
EyePoint Pharmaceuticals, Inc. 2023 Long-Term Incentive Plan
Bonus & Incentive Agreements
EyePoint Pharmaceuticals, Inc.
2023
Product Rights Agreement, dated May 17, 2023, by and between EyePoint Pharmaceuticals, Inc. and Alimera Sciences, Inc
EyePoint Pharmaceuticals, Inc.
2023
Commercial Supply Agreement, dated May 17, 2023, by and between EyePoint Pharmaceuticals, Inc. and Alimera Sciences, Inc
Supply Agreements
EyePoint Pharmaceuticals, Inc.
2023
First Amendment to Employment Agreement, dated January 3, 2023, by and between EyePoint Pharmaceuticals, Inc. and Jay S. Duker
Employment Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
MA
2023
First Amendment to Employment Letter Agreement, dated January 3, 2023, by and between EyePoint Pharmaceuticals, Inc. and Nancy S. Lurker
Employment Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
MA
2023
Employment Agreement, dated January 3, 2023, by and between EyePoint Pharmaceuticals, Inc. and George O. Elston
Employment Agreements
EyePoint Pharmaceuticals, Inc.
2023
Employment Agreement, dated January 3, 2023, by and between EyePoint Pharmaceuticals, Inc. and Scott Jones
Employment Agreements
EyePoint Pharmaceuticals, Inc.
2023
EyePoint Pharmaceuticals, Inc. Amended and Restated 2016 Long Term Incentive Plan, as Amended
Bonus & Incentive Agreements
EyePoint Pharmaceuticals, Inc.
2022
Amendment #1 to Exclusive License Agreement, dated May 2, 2022, by and between EyePoint Pharmaceuticals, Inc. and Equinox Sciences, LLC
License Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
DE
2022
Exclusive License Agreement, dated May 2, 2022, by and between EyePoint Pharmaceuticals, Inc. and Betta Pharmaceuticals, Co., Ltd
License Agreements
EyePoint Pharmaceuticals, Inc.
2022
First Amendment to Loan and Security Agreement, dated June 2, 2022, by and among EyePoint Pharmaceuticals, Inc., EyePoint Pharmaceuticals US, Inc., Icon Bioscience, Inc. and...
Loan Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
2022
Form of Indemnification Agreement between EyePoint Pharmaceuticals, Inc. and its officers and directors
Indemnification Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
DE
2022
Fourth Amendment to Lease, dated March 8, 2022, between GRE Riverworks, LLC and EyePoint Pharmaceuticals, Inc
Lease Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
2022
Commercial Alliance Expansion Term Letter Agreement dated December 6, 2021 between EyePoint Pharmaceuticals, Inc. and ImprimisRx, LLC
EyePoint Pharmaceuticals, Inc.
2022
Loan and Security Agreement, dated March 9, 2022, among EyePoint Pharmaceuticals, Inc., EyePoint Pharmaceuticals US, Inc., Icon Bioscience, Inc. and Silicon Valley Bank
Loan Agreements
EyePoint Pharmaceuticals, Inc.
2022
Employment Agreement, dated January 10, 2022, by and between EyePoint Pharmaceuticals, Inc. and Michael, C. Pine
Employment Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
MA
2022
Underwriting Agreement, dated November 16, 2021, by and among EyePoint Pharmaceuticals, Inc. and Cowen and Company, LLC and Guggenheim Securities, LLC
Underwriting Agreements
EyePoint Pharmaceuticals, Inc.
2021
Form of Pre-Funded Warrant to Purchase Common Stock
Warrant Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
NY
2021
EyePoint Pharmaceuticals, Inc. 2016 Long-Term Incentive Plan, as amended
Bonus & Incentive Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
MA
2021
EyePoint Pharmaceuticals, Inc. 2019 Employee Stock Purchase Plan, as amended
Stock Agreements
EyePoint Pharmaceuticals, Inc.
2021
Third Amendment to Lease, dated April 5, 2021, between GRE Riverworks, LLC and EyePoint Pharmaceuticals, Inc
Lease Agreements
EyePoint Pharmaceuticals, Inc.
2021
Amendment No. 3 and Waiver To Term Loan Agreement, dated May 3, 2021, among EyePoint Pharmaceuticals, Inc. as Borrower, EyePoint Pharmaceuticals US, Inc. and Icon Bioscience,...
Loan Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
TX
2021
Description of Securities of EyePoint Pharmaceuticals, Inc
EyePoint Pharmaceuticals, Inc.
2021
Form of Indemnification Agreement between EyePoint Pharmaceuticals, Inc. and its officers and directors
Indemnification Agreements
EyePoint Pharmaceuticals, Inc.
2021
Amendment One to the Commercial Alliance Agreement dated November 12, 2020 between EyePoint Pharmaceuticals, Inc. and ImprimisRx, LLC
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
2021
Royalty Purchase Agreement, dated December 17, 2020, by and between EyePoint Pharmaceuticals, Inc. and SWK Funding, LLC
Purchase Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
DE
2021
Underwriting Agreement, dated February 1, 2021, by and among EyePoint Pharmaceuticals, Inc. and Cowen and Company, LLC and Guggenheim Securities, LLC
Underwriting Agreements
EyePoint Pharmaceuticals, Inc.
2021
First Amendment to Share Purchase Agreement, dated February 1, 2021, by and between EyePoint Pharmaceuticals, Inc. and Ocumension Therapeutics
Share Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
DE
2021
Share Purchase Agreement, dated December 31, 2020, by and between EyePoint Pharmaceuticals, Inc. and Ocumension Therapeutics
Share Agreements
EyePoint Pharmaceuticals, Inc.
2021
Voting and Investor Rights Agreement, dated December 31, 2020, by and among EyePoint Pharmaceuticals, Inc., Ocumension Therapeutics, and EW Healthcare Partners, L.P. and EW...
Investor Rights Agreements
EyePoint Pharmaceuticals, Inc.
2021
Commercial Alliance Agreement, dated as of August 1, 2020 between EyePoint Pharmaceuticals, Inc. and ImprimisRx, LLC
EyePoint Pharmaceuticals, Inc.
2020
Amendment No. 2 and Waiver To Term Loan Agreement, dated October 8, 2020, among EyePoint Pharmaceuticals, Inc. as Borrower, EyePoint Pharmaceuticals US, Inc. and Icon Bioscience,...
Loan Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
TX
2020
Controlled Equity OfferingSM Sales Agreement, dated August 5, 2020, by and between EyePoint Pharmaceuticals, Inc. and Cantor Fitzgerald & Co
Sales Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
NY
2020
Description of Securities of EyePoint Pharmaceuticals, Inc
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
2020
Exclusive License Agreement, dated February 3, 2020, between EyePoint Pharmaceuticals, Inc. and Equinox Science, LLC
License Agreements
EyePoint Pharmaceuticals, Inc.
2020
Underwriting Agreement, dated February 21, 2020, by and between EyePoint Pharmaceuticals, Inc. and Guggenheim Securities, LLC
Underwriting Agreements
EyePoint Pharmaceuticals, Inc.
2020
Waiver To Term Loan Agreement, dated November 19, 2019, among EyePoint Pharmaceuticals, as Borrower, EyePoint Pharmaceuticals US, Inc. and Icon Bioscience, Inc., as subsidiary...
Loan Agreements
EyePoint Pharmaceuticals, Inc.
2019
Employment Agreement, dated November 14, 2019, by and between EyePoint Pharmaceuticals, Inc. and George Elston
Employment Agreements
EyePoint Pharmaceuticals, Inc.
2019
Employment Agreement between EyePoint Pharmaceuticals, Inc. and Scott Jones, dated May 30, 2019
Employment Agreements
EyePoint Pharmaceuticals, Inc.
2019
Form of Indemnification Agreement between EyePoint Pharmaceuticals, Inc. and its officers and directors
Indemnification Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
DE
2019
EyePoint Pharmaceuticals, Inc. 2016 Long Term Incentive Plan
Bonus & Incentive Agreements
EyePoint Pharmaceuticals, Inc.
2019
Amendment No. 1 to EyePoint Pharmaceuticals, Inc. 2016 Long Term Incentive Plan
Bonus & Incentive Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
2019
EyePoint Pharmaceuticals, Inc. 2019 Employee Stock Purchase Plan
Stock Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
DE
2019
Underwriting Agreement, dated March 28, 2019, by and between EyePoint Pharmaceuticals, Inc. and Guggenheim Securities, LLC
Underwriting Agreements
EyePoint Pharmaceuticals, Inc.
2019
Fee Letter, dated February 13, 2019, by and between EyePoint Pharmaceuticals, Inc. and CRG Servicing LLC
Servicing Agreements
EyePoint Pharmaceuticals, Inc.
2019
Term Loan Agreement, dated February 13, 2019, among EyePoint Pharmaceuticals, Inc., as Borrower, EyePoint Pharmaceuticals US, Inc. and Icon Bioscience, Inc., as Subsidiary...
Loan Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
TX
2019
At Market Issuance Sales Agreement, dated January 18, 2019, between EyePoint Pharmaceuticals, Inc. and B. Riley FBR, Inc
Sales Agreements
EyePoint Pharmaceuticals, Inc.
2019
Stock Option Award Agreement, dated May 14, 2018, by and between EyePoint Pharmaceuticals, Inc. and Leonard M. Blum
Stock Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
2018
Stock Option Award Agreement, dated May 14, 2018, by and between EyePoint Pharmaceuticals, Inc. and Leonard M. Blum
Stock Agreements
EyePoint Pharmaceuticals, Inc.
2018
Stock Option Award Agreement, dated August 1, 2018, by and between EyePoint Pharmaceuticals, Inc. and David Price
Stock Agreements
EyePoint Pharmaceuticals, Inc.
2018
Performance Stock Unit Award Agreement, dated August 1, 2018, by and between EyePoint Pharmaceuticals, Inc. and David Price
Bonus & Incentive Agreements
EyePoint Pharmaceuticals, Inc.
2018
Stock Option Award Agreement, dated August 14, 2018, by and between EyePoint Pharmaceuticals, Inc. and John Weet
Stock Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
2018
Employment Agreement, dated May 11, 2018, by and between EyePoint Pharmaceuticals, Inc. and Leonard Blum
Employment Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
NJ
2018
Form of Stock Option Award Agreement for Inducement grants to executive officers
Stock Agreements
EyePoint Pharmaceuticals, Inc.
2018
Form of Indemnification Agreement between EyePoint Pharmaceuticals, Inc. and its officers and directors
Indemnification Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
DE
2018
EyePoint Pharmaceutical Short Term Incentive Plan
Bonus & Incentive Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
2018
First Amendment of Lease, dated February 6, 2014, between Farley White Aetna Mills, LLC and pSivida Corp
Lease Agreements
EyePoint Pharmaceuticals, Inc.
2018
Second Amendment of Lease, dated May 14, 2018, between Whetstone Riverworks Holdings, LLC and EyePoint Pharmaceuticals, Inc
Lease Agreements
EyePoint Pharmaceuticals, Inc.
2018
Employment Agreement, dated August 1, 2018, by and between EyePoint Pharmaceuticals, Inc. and David Price
Employment Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
MA
2018
Form of Warrant to Purchase Common Stock of EyePoint Pharmaceuticals, Inc., issued June 25, 2018, to the Second Tranche Investors
Warrant Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
2018
Second Registration Rights Agreement, dated as of June 25, 2018, by and among EyePoint Pharmaceuticals, Inc. and EW Healthcare Partners, L.P. and EW Healthcare Partners-A, L.P....
Registration Rights Agreements
EyePoint Pharmaceuticals, Inc.
2018
Short Term Incentive Plan
Bonus & Incentive Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
2018
Employment Agreement, dated March 27, 2018, by and between Dario Paggiarino and EyePoint Pharmaceuticals, Inc
Employment Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
MA
2018
Warrant to Purchase Common Stock of pSivida Corp., issued March 28, 2018, to SWK Funding LLC
Warrant Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
2018
Securities Purchase Agreement, dated as of March 28, 2018, by and among pSivida Corp. and EW Healthcare Partners, L.P. and EW Healthcare Partners-A, L.P
Purchase Agreements
EyePoint Pharmaceuticals, Inc.
2018
Second Securities Purchase Agreement, dated as of March 28, 2018, by and among pSivida Corp. and EW Healthcare Partners, L.P. and EW Healthcare Partners-A, L.P. and each other...
Purchase Agreements
EyePoint Pharmaceuticals, Inc.
2018
Registration Rights Agreement, dated as of March 28, 2018, by and among pSivida Corp. and EW Healthcare Partners, L.P. and EW Healthcare Partners-A, L.P
Registration Rights Agreements
EyePoint Pharmaceuticals, Inc.
2018
Credit Agreement, dated as of March 28, 2018, among pSivida Corp., SWK Funding LLC and the financial institutions party thereto from time to time as lenders
Credit Agreements
EyePoint Pharmaceuticals, Inc.
2018
Agreement and Plan of Merger, dated March 28, 2018, by and among pSivida Corp., Oculus Merger Sub, Inc., Icon Bioscience, Inc. and Shareholder Representative Services LLC
Merger Agreements
EyePoint Pharmaceuticals, Inc.
2018
Form of Stock Option Certificate for grants to executive officers under the pSivida Corp. 2016 Long Term Incentive Plan, as amended
Bonus & Incentive Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
2018
Form of Deferred Stock Unit Award for grants to non-executive directors under the pSivida Corp. 2016 Long Term Incentive Plan, as amended
Bonus & Incentive Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
DE
2018
Employment Agreement, between pSivida Corp. and Dario Paggiarino, dated July 7, 2016
Employment Agreements
EyePoint Pharmaceuticals, Inc.
2017
Form of Restricted Stock Unit Award for grants to executive officers under the pSivida Corp. 2016 Long Term Incentive Plan, as amended
Bonus & Incentive Agreements
EyePoint Pharmaceuticals, Inc.
2017
Form of Performance-Based Stock Unit Award for grants under the pSivida Corp. 2016 Long Term Incentive Plan, as amended
Bonus & Incentive Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
DE
2017
Second Amended and Restated Collaboration Agreement by and between pSivida US Inc. and Alimera Sciences, Inc. dated July 10, 2017
Collaboration Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
DE
2017
Agreement, dated April 11, 2017, by and between pSivida Corp., pSiMedica Limited and Pfizer, Inc
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
2017
pSivida Short Term Incentive Plan
Bonus & Incentive Agreements
EyePoint Pharmaceuticals, Inc.
2017
PSIVIDA CORP. 2016 LONGTERM INCENTIVE PLAN
Bonus & Incentive Agreements
EyePoint Pharmaceuticals, Inc.
2017
PSIVIDA CORP. CommonStock (par value $0.001 per share) At Market Issuance Sales Agreement
Share Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
NJ
2017
pSivida 480 Pleasant Street Suite B300 Watertown, MA 02472
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
2017
PERFORMANCE-BASED RESTRICTED STOCK UNIT AWARD AGREEMENT INDUCEMENT AWARD
Bonus & Incentive Agreements
EyePoint Pharmaceuticals, Inc.
2016
PERFORMANCE-BASED RESTRICTED STOCK UNIT AWARD AGREEMENT
Bonus & Incentive Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
2016
- 2 -
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
NJ
2016
PERFORMANCE-BASED RESTRICTED STOCK UNIT AWARD AGREEMENT INDUCEMENT AWARD
Bonus & Incentive Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
2016
Nonstatutory Stock Option Inducement Award
Stock Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
2016
- 2 -
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
MA
2016
PERFORMANCE-BASED RESTRICTED STOCK UNIT AWARD AGREEMENT
Bonus & Incentive Agreements
EyePoint Pharmaceuticals, Inc.
2016
Nonstatutory Stock Option Granted Under pSivida Corp. 2008 Incentive Plan
Bonus & Incentive Agreements
EyePoint Pharmaceuticals, Inc.
2016
AGREEMENT
EyePoint Pharmaceuticals, Inc.
2016
PSIVIDA CORP. 4,000,000Shares of Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
2016
PSIVIDA CORP.
EyePoint Pharmaceuticals, Inc.
2015
pSivida Corp. 2008 INCENTIVE PLAN (as amended in 2009)
Bonus & Incentive Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
2015
PSIVIDA CORP. CommonStock (par value $0.001 per share) At Market Issuance Sales Agreement
Share Agreements
EyePoint Pharmaceuticals, Inc.
2013
LEASE Landlord: Farley White Aetna Mills, LLC Tenant: pSivida Corp. Date of Lease: As of November 1, 2013 TABLE OF CONTENTS
Lease Agreements
EyePoint Pharmaceuticals, Inc.
2013
PSIVIDA CORP. 3,494,550 Shares of Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
2013
Rodman & Renshaw, LLC 1251 Avenue of the Americas, 20th Floor, New York, NY 10020 Tel: 212 ###-###-#### Fax: 212 ###-###-#### www.rodm.com Member: FINRA, SIPC
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
NY
2012
COMMON STOCK PURCHASE WARRANT PSIVIDA CORP.
Warrant Agreements
EyePoint Pharmaceuticals, Inc.
2012
CONFIDENTIAL TREATMENT REQUESTED
EyePoint Pharmaceuticals, Inc.
2011
pSivida Corp. 400 Pleasant Street Watertown, MA 02472
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
MA
2010
pSivida Corp. 400 Pleasant Street Watertown, MA 02472
EyePoint Pharmaceuticals, Inc.
2010
CONFIDENTIAL TREATMENT REQUESTED
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
DE
2010
pSivida KEY EMPLOYEE ANNUAL BONUS PLAN
Bonus & Incentive Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
MA
2010
SECOND AMENDMENT TO AMENDED AND RESTATED LICENSE AGREEMENT
License Agreements
EyePoint Pharmaceuticals, Inc.
2009
EXHIBIT A RELEASE OF CLAIMS
Release Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
2009
[Nonstatutory] Stock Option Granted Under pSivida Corp. 2008 Incentive Plan
Bonus & Incentive Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
2009
Nonstatutory Stock Option Granted Under pSivida Corp. 2008 Incentive Plan
Bonus & Incentive Agreements
EyePoint Pharmaceuticals, Inc.
2008
AMENDED AND RESTATED COLLABORATION AGREEMENT
Collaboration Agreements
EyePoint Pharmaceuticals, Inc.
2008